Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections.
about
The pharmacokinetics and pharmacodynamics of the carbapanemes: focus on doripenemMeasurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS).In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.Barriers to intravenous penicillin use for treatment of nonmeningitis pneumococcal disease.Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media.Veterinary drug usage and antimicrobial resistance in bacteria of animal origin.Validation and Application of a Dried Blood Spot Ceftriaxone Assay.Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.Pharmacological rationale for antibiotic treatment of intra-abdominal infections.A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii.Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae.An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung.Comparison of adherence between twice- and thrice-daily regimens of oral amoxicillin/clavulanic acid
P2860
Q28289744-290D6273-7696-4EE8-8831-204ECBE5C79AQ33675064-D90CF314-7FF3-43BF-9DAB-7ADE01EB1FE3Q33876423-FB9F0D0F-D1BD-4E58-B8B6-9B6A48C43030Q34058316-E296F9A1-8437-4D18-8471-1BEF56599C91Q34120415-199C158F-FAF9-427B-8AD8-D21ABB8766C8Q35364184-3B724878-DA36-4600-8D17-E4ED1D2082B8Q36065193-8DBE0B6E-7B3C-4191-9DBD-C0461E818C54Q36439065-51BF2C3E-4EB7-4B9D-885A-B81FD371BF5BQ37120112-B0ED7632-E15A-4ADA-AD56-E68D89521134Q37557851-FCA5FD40-7788-4268-8C24-8AECA237462CQ40360159-A083B0F6-8E96-45E2-AB65-992E62F7B1B8Q42588180-4434D2A6-6EF4-427E-A80D-A2D92075EF2DQ44510164-E3CADA04-0322-4E43-A309-BC433D41A33AQ46559931-A91F199B-85B4-4C40-84BF-128B006581A2Q57777837-44AE8F9C-904D-4D5E-B93E-D22F6C04FDF9
P2860
Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@ast
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@en
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@nl
type
label
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@ast
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@en
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@nl
prefLabel
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@ast
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@en
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@nl
P1476
Pharmacokinetic and pharmacody ...... respiratory tract infections.
@en
P2093
P304
P356
10.1097/00001432-200104000-00010
P577
2001-04-01T00:00:00Z